BACKGROUND Novel minimally invasive mitral valve interventions for dysfunctional mitral bioprosthesis are being performed through the apex of the left ventricle. This Transapical approach is also being developed to replace diseased native mitral valve using new generations of catheter-mounted prosthesis. These procedures are imagingguided in the main and do not permit direct visual assessment of the mitral valve. We postulate that Cardiac-gated Contrast-enhanced Multidetector Computed Tomography (CC-MDCT) imaging of the mitral prosthesis or native mitral valve can be accurately performed, and yields useful information to enhance procedural success.
BACKGROUND Standard risk stratification methods are incapable of identifying many individuals subsequently experiencing major adverse cardiovascular events (MACE). Coronary artery calcification (CAC) is a powerful predictor of MACE however the routine use of this technique is limited by radiation exposure and cost. MicroRNAs are small, non-coding RNAs that regulate transcription. Their dysregulation is widely accepted to signify a number of disease states. We aimed to establish whether a peripheral blood-based microRNA profile was predictive of the presence and degree of human CAC.
METHODS Study subjects met the following inclusion criteria: attendance for routine cardiac computed tomography; 18-65 years of age; no established coronary artery disease, cardiac failure or tachyarrhythmia; no renal impairment; no diabetes mellitus; no autoimmune disease; no infection; no active cancer. Peripheral venesection was undertaken and an Agatston score was derived using default software. Leukocyte RNA was isolated with the LeukoLOCK Total RNA Isolation System and stored at -80 C until Toray's microarray analysis was performed.
RESULTS Twenty-four eligible participants entered into the study (mean age 54 years; 67% male). They were categorized by CAC score: [CAC score 0] n¼6; [CAC score 1-10] n¼6; [CAC score 11-100] n ¼ 6; [CAC score > 100] n ¼ 6. The groups had similar baseline clinical characteristics according to age, gender and prior history of hypertension, dyslipidemia and smoking. MiR-1181 was expressed significantly less in all case groups compared to controls:
Additionally there was significant downregulation of miR-138-2-3p, miR-6816-3p and miR-8059 in those with a CAC score > 100 compared to controls (ES ¼ 3, p < 0.001; ES ¼ 2.87, p < 0.001; ES ¼ 2.6, p ¼ 0.001 respectively); figure 1.
CONCLUSIONS Human blood-based miRNA-1181 appears to predict the presence and degree of CAC. Likewise miR-138-2-3p, miR-6816-3p and miR-8059 are differentially expressed in patients with high CAC scores in comparison to their matched controls. We plan to test these findings further with quantitative real-time PCR and in a prospective validation cohort. Ultimately a miRNA signature may explain the mechanisms underpinning CAC and could serve as a novel, and longawaited, biomarker for MACE. METHODS 12 patients (61AE5 yrs) with Type-B dissections underwent TEVAR with exclusion of the left subclavian artery (LSA). CTA images were acquired pre-and post-TEVAR, and 3D models of the thoracic aorta and arch branches were constructed to quantify geometry (Fig. 1) . Landing location was defined as the relative position of the proximal end of the graft to the LSA. Branch angles were computed relative to the aortic centerline. Curvature was computed as the inverse of radius of a circumscribed circle along the aorta. Pearson's coefficient (R) was computed to quantify the correlation between geometric changes and landing location.
RESULTS
The time interval between pre-and post-TEVAR was 4 AE 4 months. The landing location was proximal to the LSA by 21 AE 17 mm. Compared to pre-TEVAR geometry, the stented aorta increased peak curvature post-TEVAR (P< 0.05) (Table 1) . While no significant pre-topost differences were found in branch angle and mean curvature, landing location was correlated to changes in left common carotid (LCCA) angle and arch mean curvature (R¼ 0.78 and 0.70, respectively).
CONCLUSIONS Peak curvature of the aorta increased with TEVAR likely due to the stiffness discontinuity introduced by the endograft. Change of arch branch geometry due to TEVAR was not significant but correlated to proximal landing location of the endograft. When the proximal end was closer to the LCCA, the LCCA branch angled toward the arch and the arch segment was straightened, compared to pre-TEVAR. Further investigation is warranted to assess in vivo motion of thoracic aorta, due to cardiac pulsatility and respiration, before and after TEVAR. 
